| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 08.06. | Agape ATP Corp - S-1, General form for registration of securities | 3 | SEC Filings | ||
| 28.05. | Morning Market Movers: Intercont (Cayman), Agape ATP, Astrotech, Snowflake See Big Swings | 675 | AFX News | TOKYO (dpa-AFX) - At 8:05 a.m. ET on Thursday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| 15.05. | Agape ATP Corp - 10-Q, Quarterly Report | 4 | SEC Filings | ||
| 13.04. | Agape ATP Corp - 10-K, Annual Report | - | SEC Filings | ||
| 31.03. | Agape ATP Corp - NT 10-K, Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 | - | SEC Filings | ||
| 12.03. | Agape ATP regains Nasdaq compliance; shares up over 33% | 5 | Seeking Alpha | ||
| 12.03. | Agape ATP Corporation Regains Compliance with Nasdaq Minimum Bid Price Requirement | 335 | ACCESS Newswire | KUALA LUMPUR, MY / ACCESS Newswire / March 12, 2026 / Agape ATP Corporation (NASDAQ:ATPC) ("ATPC" or "the Company") announced today that it has received confirmation from The Nasdaq Stock Market LLC... ► Artikel lesen | |
| AGAPE ATP Aktie jetzt für 0€ handeln | |||||
| 10.03. | AGAPE ATP Corporation Forges Strategic Collaboration with UAE-Based Citadel Investment | 871 | ACCESS Newswire | KUALA LUMPUR, MY / ACCESS Newswire / March 10, 2026 / NASDAQ-listed AGAPE ATP Corporation ("ATPC") through its subsidiary ATPC Green Energy Sdn. Bhd., has entered into a Collaboration Agreement with... ► Artikel lesen | |
| 10.03. | Agape ATP Corp - 8-K, Current Report | 2 | SEC Filings | ||
| 06.02. | Agape ATP Corporation Announces 1-For-50 Reverse Stock Split | 508 | ACCESS Newswire | KUALA LUMPUR, MY / ACCESS Newswire / February 6, 2026 / Agape ATP Corporation (NASDAQ:ATPC) ("ATPC" or "the Company") announced that it intends to implement a 1-for-50 reverse stock split of its issued... ► Artikel lesen | |
| 05.02. | Agape ATP announces potential Nasdaq delisting over low share price; shares down | 5 | Seeking Alpha | ||
| 05.02. | Agape ATP Corporation Receives Nasdaq Delisting Notice | 269 | ACCESS Newswire | KUALA LUMPUR, MY / ACCESS Newswire / February 5, 2026 / Agape ATP Corporation (NASDAQ:ATPC) ("ATPC" or "the Company") announced that it has received a notification from The Nasdaq Stock Market LLC ("Nasdaq")... ► Artikel lesen | |
| 05.02. | Agape ATP Corp - 8-K, Current Report | 4 | SEC Filings | ||
| 02.02. | Agape ATP: Aktionäre stimmen allen Vorschlägen auf der Jahreshauptversammlung zu | 2 | Investing.com Deutsch | ||
| 29.01. | Agape ATP Corp - 8-K, Current Report | 2 | SEC Filings | ||
| 29.01. | Agape ATP erhält Rüge der NASDAQ wegen Nichterfüllung der Mindestkursanforderung | - | Investing.com Deutsch | ||
| 29.01. | Agape ATP receives Nasdaq notification | 1 | Seeking Alpha | ||
| 29.01. | Agape ATP Corporation Receives Nasdaq Notice on Minimum Bid Price Requirement | 466 | ACCESS Newswire | KUALA LUMPUR, MY / ACCESS Newswire / January 29, 2026 / Agape ATP Corporation (NASDAQ:ATPC) ("ATPC" or "the Company") announced that it received a notification letter from the Listing Qualifications... ► Artikel lesen | |
| 12.12.25 | Agape ATP Corporation Issues Statement on Recent Market Activity and Reaffirms Strategic Outlook | 470 | ACCESS Newswire | KUALA LUMPUR, MY / ACCESS Newswire / December 12, 2025 / Agape ATP Corporation (NASDAQ:ATPC) ("ATPC" or "the Company") a provider of health and wellness products and sustainable energy solutions, today... ► Artikel lesen | |
| 08.07.25 | Agape ATP Corporation Signs Strategic Partnerships Agreement to Advance Global Energy and Infrastructure Initiatives | 1.545 | ACCESS Newswire | KUALA LUMPUR, MY / ACCESS Newswire / July 8, 2025 / NASDAQ-listed AGAPE ATP Corporation ("ATPC") through its subsidiary ATPC Green Energy Sdn. Bhd., has entered into a strategic partnership agreement... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ATOSSA THERAPEUTICS | 1,770 | +1,14 % | Atossa Therapeutics Inc: Atossa Therapeutics Announces Closing of Registered Direct Offering of up to $16.5 Million in Gross Proceeds | $4.5 million upfront with up to an additional $12 million of potential aggregate gross proceeds upon exercise in full of warrants
SEATTLE, June 12, 2026 /PRNewswire/... ► Artikel lesen | |
| BEYOND AIR | 0,365 | +1,39 % | Beyond Air, Inc. Urges Stockholders to Vote "FOR" All Proposals Ahead of the Upcoming Special Meeting | Special Meeting of Stockholders Scheduled for June 18, 2026 at 4:30 p.m. Eastern Time Proxies have been mailed to stockholders of record as of the close of business on April 20, 2026; contact information... ► Artikel lesen | |
| AXOGEN | 38,420 | 0,00 % | Axogen, Inc.: Axogen Announces Pricing of Upsized $124 Million Public Offering of Common Stock | ALACHUA, Fla. and TAMPA, Fla., Jan. 21, 2026 (GLOBE NEWSWIRE) -- Axogen, Inc. (Nasdaq: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral... ► Artikel lesen | |
| AXE COMPUTE | 5,600 | -9,68 % | Axe Compute Inc: Axe Compute Secures $25.9 Million in Contracts for Long-Term Deployments of Blackwell and Grace Blackwell Compute | ||
| AVANOS MEDICAL | 21,400 | 0,00 % | Avanos Medical, Inc. Announces First Quarter 2026 Results | Delivered double-digit organic growth led by Specialty Nutrition Systems segment
Generated $0.11 of diluted earnings per share and $0.22 of adjusted diluted earnings... ► Artikel lesen | |
| AETHLON MEDICAL | 1,910 | +1,06 % | Aethlon Medical, Inc.: Aethlon Medical Announces Fiscal Year End March 31, 2026 Financial Results and Corporate Update | Australian oncology study advances into Cohort 3 as enrollment continues
Entered the third and final dosing cohort of the Australian oncology study, expanded the... ► Artikel lesen | |
| APYX MEDICAL | 3,500 | -2,23 % | Apyx Medical Corporation (APYX): a High Growth Micro-Cap Stock Improving Cellulite and Skin laxity | ||
| ANGIODYNAMICS | 10,400 | -0,95 % | AngioDynamics wins FDA IDE for feasibility study of NanoKnife in BPH | ||
| BLUEJAY DIAGNOSTICS | 4,460 | 0,00 % | Morning Market Movers: Bluejay Diagnostics, Decent Holding, Abits Group, Sunshine Biopharma See Big Swings | WASHINGTON (dpa-AFX) - At 7:35 a.m. ET on Tuesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| ALLURION TECHNOLOGIES | - | - | Allurion Technologies, Inc. Advances Plan to Re-List / Announces a 1-for-15 reverse stock split | NATICK, Mass.--(BUSINESS WIRE)--Allurion Technologies, Inc. (OTCQB: ALUR), a pioneer in metabolically healthy weight loss, today announced a 1-for-15 reverse stock of its outstanding common stock intended... ► Artikel lesen | |
| AUTONOMIX MEDICAL | 0,384 | +5,30 % | Autonomix Medical, Inc.: Autonomix Announces Reverse Stock Split | THE WOODLANDS, TX, June 18, 2026 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) ("Autonomix" or the "Company"), a medical device company dedicated to advancing precision nerve-targeted... ► Artikel lesen | |
| AESTHETIC MEDICAL INTERNATIONAL | 0,009 | 0,00 % | XFRA 3FMA,833: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILAEST.MED.INT.HLD.SP.ADR/3... ► Artikel lesen | |
| BONE BIOLOGICS | 1,480 | +1,37 % | BONE BIOLOGICS CORPORATION: Bone Biologics Highlights 2025 Key Operational, Scientific, and Corporate Milestones and Provides 2026 Outlook | BURLINGTON, Mass., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Bone Biologics Corporation ("Bone Biologics" or the "Company") (NASDAQ: BBLG, BBLGW), a developer of orthobiologic products for spine fusion markets... ► Artikel lesen | |
| BRAINSWAY | 14,900 | +0,07 % | H.C. Wainwright reiterates Brainsway stock rating on Valor ties | ||
| BAIRD MEDICAL | 1,160 | +4,50 % | BDMD: Baird Medical Reports Full Year 2025 Financial Results and Provides Corporate Update | Full year 2025 revenue of $22.5 million, impacted by policy-driven slowdown in Mainland China
Advancing global expansion with appointment of seasoned commercial leader... ► Artikel lesen |